A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer made ...

Pfizer (PFE) CEO and chairman Albert Bourla told Yahoo Finance Executive Editor Brian Sozzi during Yahoo Finance's annual Investconference that the $10 billion acquisition of GLP-1 maker Metsera (MTSR ...

Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once ...

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a market analyst who compared the drug to a rival injection from Pfizer. The comment comes as drugmakers race to meet ...

Pfizer says it's blocking use of its drugs for lethal injections, an announcement with limited immediate impact that nonetheless means all federally-approved drugmakers whose medications could be used ...

The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...